United States Biotechnology & Medical Research

Savara Inc (SVRA)

Track

Track

Savara Inc experienced significant insider trading activity recently, characterized by a net negative value of approximately 4.48 million dollars. Chief Financial Officer David L. Lowrance executed substantial sell orders totaling over 4.48 million dollars in June 2026. These divestments occurred following the company's latest earnings report, which reflected a negative earnings per share variance.
Ticker: SVRA Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Savara Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.3
Lowrance David L Chief Financial Officer Officer
Transaction date
Sale
Price
53.06
Quantity 2,947 +47.8%
Value US$4,264,747
3.3
Lowrance David L Chief Financial Officer Officer
Transaction date
Sale
Price
354.63
Quantity 42,316 -37.5%
Value US$2,957,287
3.3
Lowrance David L Officer Officer
Transaction date
Proposed sale
Price
333.46
Quantity 6,895
Value US$971,610
3.3
Lowrance David L Officer Officer
Transaction date
Proposed sale
Price
5.65
Quantity 394,528
Value US$2,229,000
3.5
RAMSAY DAVID A Non-Executive Director
Transaction date
Sale
Price
6.06
Quantity 20,000 -0.8%
Value US$121,220
3.5
RAMSAY DAVID A Director Non-Executive Director
Transaction date
Proposed sale
Price
6.11
Quantity 20,000
Value US$122,200
4.2
Hawkins Richard J Non-Executive Director
Transaction date
Purchase
Price
2.04
Quantity 48,225 +71.7%
Value US$98,572
2.6
McCracken Joseph S Non-Executive Director
Transaction date
Purchase
Price
2.08
Quantity 10,000 +4.0%
Value US$20,825
3.5
RAMSAY DAVID A Non-Executive Director
Transaction date
Purchase
Price
2.78
Quantity 150,000 +6.3%
Value US$416,250
2.8
Pauls Matthew Director Non-Executive Director
Transaction date
Proposed sale
Price
3.31
Quantity 54,702
Value US$180,800
4.2
Hawkins Richard J Director Non-Executive Director
Transaction date
Proposed sale
Price
3.29
Quantity 8,000
Value US$26,300
3.3
Lowrance David L Officer Officer
Transaction date
Proposed sale
Price
3.30
Quantity 25,000
Value US$82,500
3.3
Lowrance David L Chief Financial Officer Officer
Transaction date
Sale
Price
3.33
Quantity 25,000 -6.2%
Value US$83,278
4.2
Hawkins Richard J Non-Executive Director
Transaction date
Sale
Price
3.32
Quantity 8,000 -10.6%
Value US$26,569
2.8
Pauls Matthew CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Sale
Price
3.31
Quantity 54,702 -3.4%
Value US$180,828
2.6
McCracken Joseph S Non-Executive Director
Transaction date
Purchase
Price
2.95
Quantity 20,000 +10.5%
Value US$59,072
3.5
RAMSAY DAVID A Non-Executive Director
Transaction date
Purchase
Price
2.88
Quantity 100,000 +4.5%
Value US$287,600
2.8
Pauls Matthew CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Sale
Price
4.71
Quantity 84,000 -6.1%
Value US$395,900
3.3
Elam Nevan C Non-Executive Director
Transaction date
Sale
Price
4.71
Quantity 93,843 -80.7%
Value US$442,291
3.3
Lowrance David L CHIEF FINANCIAL OFFICER Officer
Transaction date
Sale
Price
4.71
Quantity 10,000 -2.8%
Value US$47,131
2.8
Pauls Matthew Officer; Director Executive Director
Transaction date
Proposed sale
Price
4.74
Quantity 84,000
Value US$398,000
3.3
Lowrance David L Officer Officer
Transaction date
Proposed sale
Price
4.74
Quantity 10,000
Value US$47,400
3.3
Elam Nevan C Director Non-Executive Director
Transaction date
Proposed sale
Price
4.78
Quantity 93,843
Value US$448,569
2.5
BASKETT FOREST Large shareholder
Transaction date
Purchase
Price
3.00
Quantity 333,333 +1.4%
Value US$999,999
2.4
SANDELL SCOTT D Large shareholder
Transaction date
Purchase
Price
3.00
Quantity 333,333 +1.4%
Value US$999,999
2.7
Florence Anthony A. Jr. Large shareholder
Transaction date
Purchase
Price
3.00
Quantity 333,333 +1.4%
Value US$999,999
1.5
Behbahani Ali Large shareholder
Transaction date
Purchase
Price
3.00
Quantity 333,333 +1.4%
Value US$999,999
3.3
Yang Rick Large shareholder
Transaction date
Purchase
Price
3.00
Quantity 333,333 +1.4%
Value US$999,999
3.6
Chang Carmen Large shareholder
Transaction date
Purchase
Price
3.00
Quantity 333,333 +1.4%
Value US$999,999
3.9
Walker Paul Edward Large shareholder
Transaction date
Purchase
Price
3.00
Quantity 333,333 +1.4%
Value US$999,999
3.3
Mathers Edward T Large shareholder
Transaction date
Purchase
Price
3.00
Quantity 333,333 +1.4%
Value US$999,999
2.8
Makhzoumi Mohamad Large shareholder
Transaction date
Purchase
Price
3.00
Quantity 333,333 +1.4%
Value US$999,999
3.6
Pratt Raymond Dennis Chief Medical Officer Officer
Transaction date
Purchase
Price
2.93
Quantity 6,500 +4.2%
Value US$19,045
3.5
RAMSAY DAVID A Non-Executive Director
Transaction date
Purchase
Price
2.63
Quantity 37,124 +1.7%
Value US$97,599
3.5
RAMSAY DAVID A Non-Executive Director
Transaction date
Purchase
Price
2.57
Quantity 12,876 +0.6%
Value US$33,130
3.5
RAMSAY DAVID A Non-Executive Director
Transaction date
Purchase
Price
2.56
Quantity 50,000 +2.4%
Value US$127,800
3.5
RAMSAY DAVID A Non-Executive Director
Transaction date
Purchase
Price
1.55
Quantity 29,000 +1.4%
Value US$44,834
3.5
RAMSAY DAVID A Non-Executive Director
Transaction date
Purchase
Price
1.54
Quantity 7,000 +0.3%
Value US$10,752
3.5
RAMSAY DAVID A Non-Executive Director
Transaction date
Purchase
Price
1.50
Quantity 3,293 +0.2%
Value US$4,923
3.5
RAMSAY DAVID A Non-Executive Director
Transaction date
Purchase
Price
1.44
Quantity 15,707 +0.8%
Value US$22,665
3.5
RAMSAY DAVID A Non-Executive Director
Transaction date
Purchase
Price
1.48
Quantity 41,414 +2.1%
Value US$61,127
3.6
Pratt Raymond Dennis Chief Medical Officer Officer
Transaction date
Purchase
Price
1.54
Quantity 3,500 +2.3%
Value US$5,402
3.5
RAMSAY DAVID A Non-Executive Director
Transaction date
Purchase
Price
1.48
Quantity 3,586 +0.2%
Value US$5,307
3.5
RAMSAY DAVID A Non-Executive Director
Transaction date
Purchase
Price
1.50
Quantity 13,830 +0.7%
Value US$20,759
3.5
RAMSAY DAVID A Non-Executive Director
Transaction date
Purchase
Price
1.49
Quantity 40,719 +2.1%
Value US$60,834
3.5
RAMSAY DAVID A Non-Executive Director
Transaction date
Purchase
Price
1.50
Quantity 341 +0.0%
Value US$512
3.5
RAMSAY DAVID A Non-Executive Director
Transaction date
Purchase
Price
1.44
Quantity 4,610 +0.2%
Value US$6,634
3.5
RAMSAY DAVID A Non-Executive Director
Transaction date
Purchase
Price
1.42
Quantity 15,495 +0.8%
Value US$22,018
3.5
RAMSAY DAVID A Non-Executive Director
Transaction date
Purchase
Price
1.42
Quantity 25,005 +1.3%
Value US$35,532
3.5
RAMSAY DAVID A Non-Executive Director
Transaction date
Purchase
Price
1.34
Quantity 16,100 +0.9%
Value US$21,606
3.5
RAMSAY DAVID A Non-Executive Director
Transaction date
Purchase
Price
1.27
Quantity 8,900 +0.5%
Value US$11,303
3.5
RAMSAY DAVID A Non-Executive Director
Transaction date
Purchase
Price
1.37
Quantity 73,893 +4.1%
Value US$101,381
3.5
RAMSAY DAVID A Non-Executive Director
Transaction date
Purchase
Price
1.38
Quantity 31,107 +1.8%
Value US$43,052
3.5
RAMSAY DAVID A Non-Executive Director
Transaction date
Purchase
Price
1.42
Quantity 30,000 +1.7%
Value US$42,660
3.5
RAMSAY DAVID A Non-Executive Director
Transaction date
Purchase
Price
1.45
Quantity 600 +0.0%
Value US$870
3.5
RAMSAY DAVID A Non-Executive Director
Transaction date
Purchase
Price
1.46
Quantity 1,400 +0.1%
Value US$2,040
3.5
RAMSAY DAVID A Non-Executive Director
Transaction date
Purchase
Price
1.44
Quantity 6,000 +0.3%
Value US$8,652
3.5
RAMSAY DAVID A Non-Executive Director
Transaction date
Purchase
Price
1.40
Quantity 29,000 +1.7%
Value US$40,571
3.5
RAMSAY DAVID A Non-Executive Director
Transaction date
Purchase
Price
1.39
Quantity 2,130 +0.1%
Value US$2,950
3.5
RAMSAY DAVID A Non-Executive Director
Transaction date
Purchase
Price
1.38
Quantity 870 +0.1%
Value US$1,201
3.5
RAMSAY DAVID A Non-Executive Director
Transaction date
Purchase
Price
1.42
Quantity 39,768 +2.4%
Value US$56,471
3.5
RAMSAY DAVID A Non-Executive Director
Transaction date
Purchase
Price
1.42
Quantity 39,494 +2.4%
Value US$56,200
3.5
RAMSAY DAVID A Non-Executive Director
Transaction date
Purchase
Price
1.41
Quantity 20,738 +1.3%
Value US$29,261
3.5
RAMSAY DAVID A Non-Executive Director
Transaction date
Purchase
Price
1.45
Quantity 39,000 +2.5%
Value US$56,355
3.5
RAMSAY DAVID A Non-Executive Director
Transaction date
Purchase
Price
1.38
Quantity 21,094 +1.4%
Value US$29,110
3.5
RAMSAY DAVID A Non-Executive Director
Transaction date
Purchase
Price
1.33
Quantity 39,906 +2.7%
Value US$52,915
3.3
Lowrance David L CHIEF FINANCIAL OFFICER Officer
Transaction date
Purchase
Price
1.14
Quantity 4,000 +2.9%
Value US$4,569
3.5
RAMSAY DAVID A Non-Executive Director
Transaction date
Purchase
Price
1.13
Quantity 25,000 +1.8%
Value US$28,225
3.5
RAMSAY DAVID A Non-Executive Director
Transaction date
Purchase
Price
1.08
Quantity 15,000 +1.1%
Value US$16,260
3.5
RAMSAY DAVID A Non-Executive Director
Transaction date
Purchase
Price
1.04
Quantity 35,000 +2.5%
Value US$36,365
3.1
Chowdhury Badrul A. CHIEF MEDICAL OFFICER Officer
Transaction date
Purchase
Price
1.05
Quantity 25,000 +16.7%
Value US$26,250
3.5
RAMSAY DAVID A Non-Executive Director
Transaction date
Purchase
Price
1.05
Quantity 13,157 +1.0%
Value US$13,815
2.8
Pauls Matthew CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
1.06
Quantity 6,500 +1.7%
Value US$6,889
3.5
RAMSAY DAVID A Non-Executive Director
Transaction date
Purchase
Price
1.05
Quantity 11,843 +0.9%
Value US$12,400
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-22 2026-06-22 S Sale
3.3
Lowrance David L

Chief Financial Officer

Officer
2,947 +47.8%
53.06
US$4,264,747 		2,947 +47.8% 53.06 US$4,264,747
2026-06-22 2026-06-22 S Sale
3.3
Lowrance David L

Chief Financial Officer

Officer
42,316 -37.5%
354.63
US$2,957,287 		42,316 -37.5% 354.63 US$2,957,287
2026-06-22 2026-06-22 PrS Proposed sale
3.3
Lowrance David L

Officer

Officer
6,895
333.46
US$971,610 		6,895 333.46 US$971,610
2026-06-22 2026-06-22 PrS Proposed sale
3.3
Lowrance David L

Officer

Officer
394,528
5.65
US$2,229,000 		394,528 5.65 US$2,229,000
2025-12-19 2025-12-19 S Sale
3.5
RAMSAY DAVID A
Non-Executive Director
20,000 -0.8%
6.06
US$121,220 		20,000 -0.8% 6.06 US$121,220
2025-12-18 2025-12-18 PrS Proposed sale
3.5
RAMSAY DAVID A

Director

Non-Executive Director
20,000
6.11
US$122,200 		20,000 6.11 US$122,200
2025-06-23 2025-06-20 B Purchase
4.2
Hawkins Richard J
Non-Executive Director
48,225 +71.7%
2.04
US$98,572 		48,225 +71.7% 2.04 US$98,572
2025-06-02 2025-05-29 B Purchase
2.6
McCracken Joseph S
Non-Executive Director
10,000 +4.0%
2.08
US$20,825 		10,000 +4.0% 2.08 US$20,825
2025-04-01 2025-03-31 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
150,000 +6.3%
2.78
US$416,250 		150,000 +6.3% 2.78 US$416,250
2024-12-16 2024-12-16 PrS Proposed sale
2.8
Pauls Matthew

Director

Non-Executive Director
54,702
3.31
US$180,800 		54,702 3.31 US$180,800
2024-12-16 2024-12-16 PrS Proposed sale
4.2
Hawkins Richard J

Director

Non-Executive Director
8,000
3.29
US$26,300 		8,000 3.29 US$26,300
2024-12-16 2024-12-16 PrS Proposed sale
3.3
Lowrance David L

Officer

Officer
25,000
3.30
US$82,500 		25,000 3.30 US$82,500
2024-12-16 2024-12-16 S Sale
3.3
Lowrance David L

Chief Financial Officer

Officer
25,000 -6.2%
3.33
US$83,278 		25,000 -6.2% 3.33 US$83,278
2024-12-16 2024-12-16 S Sale
4.2
Hawkins Richard J
Non-Executive Director
8,000 -10.6%
3.32
US$26,569 		8,000 -10.6% 3.32 US$26,569
2024-12-16 2024-12-16 S Sale
2.8
Pauls Matthew

CHIEF EXECUTIVE OFFICER

Executive Director
54,702 -3.4%
3.31
US$180,828 		54,702 -3.4% 3.31 US$180,828
2024-11-20 2024-11-19 B Purchase
2.6
McCracken Joseph S
Non-Executive Director
20,000 +10.5%
2.95
US$59,072 		20,000 +10.5% 2.95 US$59,072
2024-11-18 2024-11-18 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
100,000 +4.5%
2.88
US$287,600 		100,000 +4.5% 2.88 US$287,600
2023-12-29 2023-12-28 S Sale
2.8
Pauls Matthew

CHIEF EXECUTIVE OFFICER

Executive Director
84,000 -6.1%
4.71
US$395,900 		84,000 -6.1% 4.71 US$395,900
2023-12-29 2023-12-28 S Sale
3.3
Elam Nevan C
Non-Executive Director
93,843 -80.7%
4.71
US$442,291 		93,843 -80.7% 4.71 US$442,291
2023-12-29 2023-12-28 S Sale
3.3
Lowrance David L

CHIEF FINANCIAL OFFICER

Officer
10,000 -2.8%
4.71
US$47,131 		10,000 -2.8% 4.71 US$47,131
2023-12-28 2023-12-28 PrS Proposed sale
2.8
Pauls Matthew

Officer; Director

Executive Director
84,000
4.74
US$398,000 		84,000 4.74 US$398,000
2023-12-28 2023-12-28 PrS Proposed sale
3.3
Lowrance David L

Officer

Officer
10,000
4.74
US$47,400 		10,000 4.74 US$47,400
2023-12-28 2023-12-28 PrS Proposed sale
3.3
Elam Nevan C

Director

Non-Executive Director
93,843
4.78
US$448,569 		93,843 4.78 US$448,569
2023-07-19 2023-07-17 B Purchase
2.5
BASKETT FOREST
Large shareholder
333,333 +1.4%
3.00
US$999,999 		333,333 +1.4% 3.00 US$999,999
2023-07-19 2023-07-17 B Purchase
2.4
SANDELL SCOTT D
Large shareholder
333,333 +1.4%
3.00
US$999,999 		333,333 +1.4% 3.00 US$999,999
2023-07-19 2023-07-17 B Purchase
2.7
Florence Anthony A. Jr.
Large shareholder
333,333 +1.4%
3.00
US$999,999 		333,333 +1.4% 3.00 US$999,999
2023-07-19 2023-07-17 B Purchase
1.5
Behbahani Ali
Large shareholder
333,333 +1.4%
3.00
US$999,999 		333,333 +1.4% 3.00 US$999,999
2023-07-19 2023-07-17 B Purchase
3.3
Yang Rick
Large shareholder
333,333 +1.4%
3.00
US$999,999 		333,333 +1.4% 3.00 US$999,999
2023-07-19 2023-07-17 B Purchase
3.6
Chang Carmen
Large shareholder
333,333 +1.4%
3.00
US$999,999 		333,333 +1.4% 3.00 US$999,999
2023-07-19 2023-07-17 B Purchase
3.9
Walker Paul Edward
Large shareholder
333,333 +1.4%
3.00
US$999,999 		333,333 +1.4% 3.00 US$999,999
2023-07-19 2023-07-17 B Purchase
3.3
Mathers Edward T
Large shareholder
333,333 +1.4%
3.00
US$999,999 		333,333 +1.4% 3.00 US$999,999
2023-07-19 2023-07-17 B Purchase
3.2
Growth Equity Opportunities 17, LLC
Large shareholder
333,333 +1.4%
3.00
US$999,999 		333,333 +1.4% 3.00 US$999,999
2023-07-19 2023-07-17 B Purchase
2.8
Makhzoumi Mohamad
Large shareholder
333,333 +1.4%
3.00
US$999,999 		333,333 +1.4% 3.00 US$999,999
2023-06-27 2023-06-26 B Purchase
3.6
Pratt Raymond Dennis

Chief Medical Officer

Officer
6,500 +4.2%
2.93
US$19,045 		6,500 +4.2% 2.93 US$19,045
2023-05-26 2023-05-26 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
37,124 +1.7%
2.63
US$97,599 		37,124 +1.7% 2.63 US$97,599
2023-05-26 2023-05-25 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
12,876 +0.6%
2.57
US$33,130 		12,876 +0.6% 2.57 US$33,130
2023-05-26 2023-05-24 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
50,000 +2.4%
2.56
US$127,800 		50,000 +2.4% 2.56 US$127,800
2023-01-03 2022-12-30 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
29,000 +1.4%
1.55
US$44,834 		29,000 +1.4% 1.55 US$44,834
2023-01-03 2022-12-29 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
7,000 +0.3%
1.54
US$10,752 		7,000 +0.3% 1.54 US$10,752
2022-12-28 2022-12-28 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
3,293 +0.2%
1.50
US$4,923 		3,293 +0.2% 1.50 US$4,923
2022-12-28 2022-12-23 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
15,707 +0.8%
1.44
US$22,665 		15,707 +0.8% 1.44 US$22,665
2022-12-22 2022-12-22 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
41,414 +2.1%
1.48
US$61,127 		41,414 +2.1% 1.48 US$61,127
2022-12-22 2022-12-22 B Purchase
3.6
Pratt Raymond Dennis

Chief Medical Officer

Officer
3,500 +2.3%
1.54
US$5,402 		3,500 +2.3% 1.54 US$5,402
2022-12-22 2022-12-20 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
3,586 +0.2%
1.48
US$5,307 		3,586 +0.2% 1.48 US$5,307
2022-12-20 2022-12-20 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
13,830 +0.7%
1.50
US$20,759 		13,830 +0.7% 1.50 US$20,759
2022-12-20 2022-12-19 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
40,719 +2.1%
1.49
US$60,834 		40,719 +2.1% 1.49 US$60,834
2022-12-20 2022-12-16 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
341 +0.0%
1.50
US$512 		341 +0.0% 1.50 US$512
2022-11-25 2022-11-23 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
4,610 +0.2%
1.44
US$6,634 		4,610 +0.2% 1.44 US$6,634
2022-11-25 2022-11-22 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
15,495 +0.8%
1.42
US$22,018 		15,495 +0.8% 1.42 US$22,018
2022-11-21 2022-11-21 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
25,005 +1.3%
1.42
US$35,532 		25,005 +1.3% 1.42 US$35,532
2022-11-21 2022-11-18 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
16,100 +0.9%
1.34
US$21,606 		16,100 +0.9% 1.34 US$21,606
2022-11-21 2022-11-17 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
8,900 +0.5%
1.27
US$11,303 		8,900 +0.5% 1.27 US$11,303
2022-09-27 2022-09-27 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
73,893 +4.1%
1.37
US$101,381 		73,893 +4.1% 1.37 US$101,381
2022-09-27 2022-09-26 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
31,107 +1.8%
1.38
US$43,052 		31,107 +1.8% 1.38 US$43,052
2022-09-27 2022-09-23 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
30,000 +1.7%
1.42
US$42,660 		30,000 +1.7% 1.42 US$42,660
2022-09-20 2022-09-20 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
600 +0.0%
1.45
US$870 		600 +0.0% 1.45 US$870
2022-09-20 2022-09-19 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
1,400 +0.1%
1.46
US$2,040 		1,400 +0.1% 1.46 US$2,040
2022-09-20 2022-09-16 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
6,000 +0.3%
1.44
US$8,652 		6,000 +0.3% 1.44 US$8,652
2022-09-08 2022-09-08 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
29,000 +1.7%
1.40
US$40,571 		29,000 +1.7% 1.40 US$40,571
2022-09-08 2022-09-07 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
2,130 +0.1%
1.39
US$2,950 		2,130 +0.1% 1.39 US$2,950
2022-09-08 2022-09-06 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
870 +0.1%
1.38
US$1,201 		870 +0.1% 1.38 US$1,201
2022-09-01 2022-09-01 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
39,768 +2.4%
1.42
US$56,471 		39,768 +2.4% 1.42 US$56,471
2022-09-01 2022-08-31 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
39,494 +2.4%
1.42
US$56,200 		39,494 +2.4% 1.42 US$56,200
2022-09-01 2022-08-30 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
20,738 +1.3%
1.41
US$29,261 		20,738 +1.3% 1.41 US$29,261
2022-06-22 2022-06-22 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
39,000 +2.5%
1.45
US$56,355 		39,000 +2.5% 1.45 US$56,355
2022-06-22 2022-06-21 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
21,094 +1.4%
1.38
US$29,110 		21,094 +1.4% 1.38 US$29,110
2022-06-22 2022-06-17 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
39,906 +2.7%
1.33
US$52,915 		39,906 +2.7% 1.33 US$52,915
2021-12-17 2021-12-17 B Purchase
3.3
Lowrance David L

CHIEF FINANCIAL OFFICER

Officer
4,000 +2.9%
1.14
US$4,569 		4,000 +2.9% 1.14 US$4,569
2021-12-17 2021-12-17 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
25,000 +1.8%
1.13
US$28,225 		25,000 +1.8% 1.13 US$28,225
2021-12-17 2021-12-15 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
15,000 +1.1%
1.08
US$16,260 		15,000 +1.1% 1.08 US$16,260
2021-12-13 2021-12-10 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
35,000 +2.5%
1.04
US$36,365 		35,000 +2.5% 1.04 US$36,365
2021-12-09 2021-12-09 B Purchase
3.1
Chowdhury Badrul A.

CHIEF MEDICAL OFFICER

Officer
25,000 +16.7%
1.05
US$26,250 		25,000 +16.7% 1.05 US$26,250
2021-12-09 2021-12-08 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
13,157 +1.0%
1.05
US$13,815 		13,157 +1.0% 1.05 US$13,815
2021-12-08 2021-12-08 B Purchase
2.8
Pauls Matthew

CHIEF EXECUTIVE OFFICER

Executive Director
6,500 +1.7%
1.06
US$6,889 		6,500 +1.7% 1.06 US$6,889
2021-12-09 2021-12-07 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
11,843 +0.9%
1.05
US$12,400 		11,843 +0.9% 1.05 US$12,400
Explore more

More insider trading research around Savara Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America